Postsurgical complication risk seen in IBD patients taking anti-TNF drugs

05/6/2013 | Medscape (free registration)

Patients who take drugs that block tumor necrosis factor alpha have a slightly higher risk of complications following surgery to treat inflammatory bowel disease, Canadian researchers reported. Dr. John Marshall of McMaster University said the study should not change physician practice, but should serve as a caution to doctors and patients that they must weigh all the risks and benefits of surgery for IBD.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT